Business Context and Reporting Period
This Form 8-K is a current report filed by eXegenics Inc. (not OPKO Health, Inc.) on January 21, 2004, covering events occurring on January 20, 2004. The registrant is a Delaware corporation listed on the Nasdaq SmallCap Market. The filing addresses regulatory compliance status, corporate address changes, and the issuance of a press release.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on regulatory and administrative events rather than financial performance data.
Material Changes
- Nasdaq Compliance Extension: The company received a determination from a Nasdaq Listings Qualification Panel granting an extension until July 25, 2004, to comply with Marketplace Rule 4450(a)(5), which mandates a $1.00 minimum share price.
- Corporate Address Change: The principal executive offices have moved to 2911 Turtle Creek Boulevard, Suite 300, Dallas, TX 75219.
- Board and Audit Committee: Recent changes to the Board of Directors and audit committee are noted; the Nasdaq Panel has not yet rendered a determination on compliance with independent director and audit committee composition requirements and has requested additional information.
Guidance, Outlook, and Risks
The filing does not contain financial guidance or management commentary on future outlook. The primary risk disclosed is the potential loss of Nasdaq listing status if the company fails to meet the minimum share price requirement by the July 25, 2004 deadline or fails to satisfy the independent director and audit committee composition requirements.
Key Facts for Investor Verification
- Verify the current share price to assess the likelihood of meeting the $1.00 minimum requirement by July 25, 2004.
- Confirm the composition of the Board of Directors and audit committee to ensure compliance with Nasdaq independence rules.
- Review the press release filed as Exhibit 99.1 for details on the events of January 20, 2004.
- Note the discrepancy between the requested company name (OPKO Health, Inc.) and the actual registrant (eXegenics Inc.).